Clinical Trial Update: Study of NC-4016 in Patients With Advanced Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 study of NC-4016 in patients with advanced solid tumors or lymphoma has completed enrollment and the trial status is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• NC-4016

Snippet

Sponsor: NanoCarrier Co., Ltd. | Conditions: Advanced Cancer, Lymphoma | Phase 1 | Status: COMPLETED